“The SIA acquisition will carry us another stage closer to achieving our ambition of getting to be a global section chief and innovator in breast reconstruction with upcoming FDA approvals, expense in pipeline and evidence generation,” claimed Jan De Witte, president and CEO, Integra LifeSciences.Participants have prospects to work with our exc